S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML

• Boglarka Gyurkocza,
• Stuart Seropian,
• Hannah Choe,
• Mark Litzow,
• Camille Abboud,
• Nebu Koshy,
• Patrick Stiff,
• Benjamin Tomlinson,
• Sunil Abhyankar,
• James M Foran,
• Parameswaran Hari,
• George Chen,
• Zaid Al-Kadhimi,
• Partow Kebriaei,
• Mitchell Sabloff,
• Johnnie Orozco,
• Katarzyna Jamieson,
• Margarida Silverman,
• Koen Van Besien,
• Michael Schuster,
• Arjun Law,
• Sameem Abedin,
• Karilyn Larkin,
• Scott Rowley,
• Pashna Munshi,
• Rachel Cook,
• Sebastian Mayer,
• Moshe Yair Levy,
• Hillard Lazarus,
• Brenda Sandmaier,
• Vijay Reddy,
• Jennifer Spross,
• Kathleen Mcnamara,
• Elaina Haeuber,
• Madhuri Vusirikala,
• Akash Nahar,
• John Pagel,
• Sergio Giralt,
• Avinash Desai,
• Rajneesh Nath

Affiliations

Boglarka Gyurkocza

1 Memorial Sloan Kettering Cancer Center, United States

Stuart Seropian

2 Yale University School of Medicine, United States

Hannah Choe

3 The Ohio State University, Division of Hematology, United States

Mark Litzow

4 Mayo Clinic

Camille Abboud

5 Washington University School of Medicine, Medicine, Division of Oncology

Nebu Koshy

6 Charles A. Sammons Cancer Center, Clinical Oncology Research, United States

Patrick Stiff

7 Loyola University Medical Center

Benjamin Tomlinson

8 University Hospitals Cleveland Medical Center, Seidman Cancer Center, United States

Sunil Abhyankar

9 Kansas University Medical Center, Division of Hematologic Malignancies and Cellular Therapeutics, United States

James M Foran

4 Mayo Clinic

Parameswaran Hari

10 Iovance Biotherapeutics, Inc., United States

George Chen

11 MD Anderson Cancer Center

Zaid Al-Kadhimi

12 University of Alabama at Birmingham, United States

Partow Kebriaei

11 MD Anderson Cancer Center

Mitchell Sabloff

13 The Ottawa Hospital, Ottawa Blood Disease Centre, Canada

Johnnie Orozco

14 Fred Hutchinson Cancer Research Center, Department of Medicine, United States

Katarzyna Jamieson

15 University of North Carolina, Lineberger Comprehensive Cancer Center, United States

Margarida Silverman

16 University of Iowa Hospitals & Clinics, United States

Koen Van Besien

17 University Hospitals Cleveland Medical Center

Michael Schuster

18 Stony Brook University Hospital

Arjun Law

19 Princess Margaret Cancer Centre

Sameem Abedin

20 Medical College of Wisconsin, Division of Hematology and Oncology

Karilyn Larkin

21 The Ohio State University, Division of Hematology

Scott Rowley

22 Hackensack University Medical Center, John Theurer Cancer Center, Adult Blood and Marrow Transplantation Program

Pashna Munshi

23 Georgetown Lombardi Comprehensive Cancer Center

Rachel Cook

24 Oregon Health & Science University

Sebastian Mayer

25 Weill Cornell Medicine, New York Presbyterian Hospital, Division of Hematology and Oncology

Moshe Yair Levy

26 Baylor University Medical Center

Hillard Lazarus

27 Case Western Reserve University

Brenda Sandmaier

28 Fred Hutchinson Cancer Research Center

Vijay Reddy

29 Redbud Medicine, China

Jennifer Spross

30 Actinium Pharmaceuticals, United States

Kathleen Mcnamara

30 Actinium Pharmaceuticals, United States

Elaina Haeuber

30 Actinium Pharmaceuticals, United States

Madhuri Vusirikala

30 Actinium Pharmaceuticals, United States

Akash Nahar

30 Actinium Pharmaceuticals, United States

John Pagel

31 Loxo Oncology at Lilly, United States

Sergio Giralt

1 Memorial Sloan Kettering Cancer Center, United States

Avinash Desai

30 Actinium Pharmaceuticals, United States

Rajneesh Nath

32 Banner MD Anderson Cancer Center, Stem Cell Transplant Cellular Therapy and Acute Leukemia, United States